Outcome survey in unselected hypertensive patients with type 2 diabetes mellitus: Effects of ACE inhibition

American Journal of Hypertension

Volumn 14, Issue 7 I, 2001, Pages 672-678

  Veelken, Roland ^a   Delles, Christian ^a   Hilgers, Karl F ^a   Schmieder, Roland E ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

ACE inhibitors; Outcome survey; Therapy; Type 2 diabetes mellitus

Indexed keywords

CILAZAPRIL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DYSPNEA; EDEMA; FEMALE; GLUCOSE METABOLISM; HEART FUNCTION; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT OUTCOME;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; CILAZAPRIL; CREATININE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; EDEMA; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, RENAL; MALE; MIDDLE AGED; PATIENT SELECTION; PROSPECTIVE STUDIES; PROTEINURIA; TREATMENT OUTCOME;

EID: 0034950199     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(01)01300-0     Document Type: Article

References (26)

1. Accelerated complications in type 2 diabetes mellitus: The need for greater awareness and earlier detection
2. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes
3. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes
4. Renal pathology patterns in type II diabetes mellitus: Relationship with retinopathy
5. Renal replacement therapy for end-stage renal failure in France: Current status and evolutive trends over the last decade
6. Type II diabetic nephropathy in perspective
7. Systemic hypertension and the renin-angiotensin system in diabetic vascular complications
8. Prevention of a first stroke: A review of guidelines and a multidisciplinary consensus statement from the National Stroke Association
9. Renal disease and hypertension in non-insulin-dependent diabetes mellitus
10. Nephropathy in type 2 diabetes
11. Guidelines for the management of hypertension. Guidelines subcommittee
12. Underestimation of the true benefits of antihypertensive treatment: An assessment of some important sources of error
13. STOP-hypertension - Preliminary communication from the pilot study of the Swedish Trial in old patients with hypertension
14. Morbidity and mortality in the Swedish Trial in old patients with hypertension (STOP-hypertension)
15. Antihypertensive therapy in the elderly: Evidence-based guidelines and reality
16. Evolution of angiotensin-converting enzyme inhibition in hypertension, heart failure, and vascular protection
17. Evidence-based medicine and ACE inhibition
18. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
19. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate risk of terminal renal failure in proteinuric non-diabetic nephropathy
20. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
21. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency
22. Assessing patient wellness: New perspectives on quality of life and compliance
23. Hypoglycaemia associated with use of inhibitors of angiotensin converting enzyme
24. Effects of long-term cilazapril treatment on glucose and lipid metabolism in hypertensive patients with non-insulin-dependent diabetes mellitus
25. Effects of atenolol versus enalapril on cardiovascular fitness and serum lipids in physically active hypertensive men